LB
55
7
BLK
49
3
PNW
69
2
GM
57
-6
MAT
30
-2
AMZN
42
-2
PEP
56
3
BBY
57
9
ABT
30
-3
ESS
33
2
FFIV
52
3
EOG
62
6
MKC
38
2
NTAP
46
3
EXR
44
4
KR
49
4
PM
41
2
LLY
67
-6
PNC
59
3
EQT
65
-3
LB
55
7
BLK
49
3
PNW
69
2
GM
57
-6
MAT
30
-2
AMZN
42
-2
PEP
56
3
BBY
57
9
ABT
30
-3
ESS
33
2
FFIV
52
3
EOG
62
6
MKC
38
2
NTAP
46
3
EXR
44
4
KR
49
4
PM
41
2
LLY
67
-6
PNC
59
3
EQT
65
-3
Financhill
Back

Dermapharm Holding SE 10K Form

Buy
91

DMPHF
Dermapharm Holding SE

Last Price:
$39.56
Seasonality Move:
-2.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DMPHF News And Ratings

See the #1 stock for the next 7 days that we like better than DMPHF

DMPHF Financial Statistics

Sales & Book Value

Annual Sales: $1.3B
Cash Flow: $41.4M
Price / Cash Flow: 16.13
Annual Sales: $14.17
Price / Book: 3.21

Profitability

EPS (TTM): 2.39420
Net Income (TTM): $127M
Gross Margin: $442.1M
Return on Equity: 18.4%
Return on Assets: 5.37%

Dermapharm Holding SE Earnings Forecast

Key Dermapharm Holding SE Financial Ratios

  • The Gross Profit Margin over the past 12 years for DMPHF is 33.62%.
  • The Selling, General & Administrative Expenses for DMPHF have been equal to 0.00% of Gross Profit Margin.
  • The Research & Development expenses have been 0.96% of Revenue.
  • The Interest Expense is 40.09% of Operating Income.
  • The Net Earning history of DMPHF is 11.28% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 8 years.

Dermapharm Holding SE Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: DMPHF
Website: dermapharm.de

Debt

Debt-to-Equity Ratio: 1.56
Current Ratio: 2.2
Quick Ratio: 0.94

Price-to-Earnings

Trailing P/E Ratio: 17.51
Forward P/E Ratio: 0

DMPHF Technical Analysis vs Fundamental Analysis

Buy
91
Dermapharm Holding SE (DMPHF) is a Buy

Is Dermapharm Holding SE a Buy or a Sell?